Hallervorden-Spatz Disease

This is a very rare disease that affects the brain and nerves. It usually starts in childhood or adolescence. People with this disease develop muscle stiffness, difficulty moving, and problems with speech. Over time, their thinking and memory get worse, leading to severe dementia.

Condition

What people with Hallervorden-Spatz Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Botox (Botulinum Toxin Type A) for Hallervorden-Spatz Disease?

NameHow it went

About Hallervorden-Spatz Disease

What It Is

Hallervorden-Spatz disease, now called pantothenate kinase-associated neurodegeneration (PKAN), is a rare inherited disorder of the nervous system that causes movement problems which worsen over time. Its central feature is dystonia: involuntary muscle contractions that twist the body into abnormal, sometimes painful postures. Stiffness, poor balance and trouble with speech and swallowing often follow. Some people also develop vision loss, behavioral or mood changes, or problems with thinking. PKAN usually begins in childhood or the teenage years and takes two broad forms. Classic PKAN starts in early childhood, often with clumsiness and frequent falls, and progresses fairly quickly. Atypical PKAN starts later, usually after age ten, and progresses more slowly; speech changes and psychiatric symptoms are often the first signs. Some people fall between the two. PKAN is the most common of a group of disorders called neurodegeneration with brain iron accumulation (NBIA), named for the abnormal iron buildup seen in deep brain areas that help control movement. The older name honors two doctors whose work was tied to unethical Nazi-era practices, which is one reason the medical community moved away from it.

Causes & Risk Factors

PKAN is caused by changes (variants) in a gene called PANK2. This gene makes an enzyme that helps cells turn vitamin B5 (pantothenate) into coenzyme A, a molecule essential for producing energy and handling fats. When the enzyme does not work, harmful substances and iron build up in parts of the brain, leading to damage. Researchers still do not fully understand how these changes produce the specific symptoms. PKAN is inherited in an autosomal recessive pattern, meaning a person must inherit a non-working copy of PANK2 from each parent. Parents who each carry one copy are usually healthy. When both parents are carriers, each pregnancy has a 25 percent (one in four) chance of a child with PKAN. The condition is more likely when parents are related by blood. It is not caused by anything a parent or child did, and taking extra vitamin B5 has not been shown to prevent or treat it.

How It's Diagnosed

A neurologist usually suspects PKAN when a child or young adult has worsening dystonia, stiffness, walking problems or speech changes. A brain MRI (magnetic resonance imaging) scan often shows a distinctive pattern called the eye-of-the-tiger sign: a dark area of iron buildup surrounding a bright spot in a movement-control region called the globus pallidus. This finding strongly points to PKAN rather than other forms of NBIA. The diagnosis is confirmed with genetic testing of the PANK2 gene. Sequencing finds both variants in most people; when it does not, a second test looking for missing or duplicated pieces of the gene is recommended. An eye exam may check for retinal degeneration, which causes night blindness and loss of side vision. Because PKAN is rare and early signs can look like clumsiness, cerebral palsy or a psychiatric illness, diagnosis is sometimes delayed. Genetic counseling helps families understand the result and the chances for siblings and future pregnancies.

Treatment Options

There is no cure, and no treatment has yet been shown to stop or reliably slow PKAN. Care focuses on easing symptoms, protecting comfort and function, and adapting as needs change. It works best with a team that may include a neurologist, physical, occupational and speech therapists, a nutrition or feeding specialist, an eye specialist and a genetic counselor. Medicines for dystonia are the main tools. Baclofen (a muscle relaxant), trihexyphenidyl (an anticholinergic drug that calms involuntary movement) and clonazepam (a sedating benzodiazepine) give the most consistent relief, though response varies and side effects such as drowsiness limit doses. Botulinum toxin injections can relax a specific troublesome area, such as the neck or jaw. Later in the disease, a surgically placed pump can deliver baclofen directly around the spinal cord. Levodopa, a Parkinson's medicine, usually does not help. When medicines are not enough, deep brain stimulation (DBS) can be considered. Thin wires placed in the globus pallidus deliver continuous electrical pulses from a battery under the skin. In published case series, DBS often eased dystonia for years, more often in atypical than classic PKAN. It does not stop the underlying disease, and swallowing and daily function can still decline. It carries surgical risks, including infection, and batteries need periodic replacement. Research treatments have so far been disappointing. In an 18-month trial, deferiprone, a drug that removes iron from the body, lowered brain iron and dystonia worsened somewhat less than with placebo, but the difference was not statistically significant and patients did not notice a change; it also caused anemia in about one in five people. Another drug, fosmetpantotenate, did not improve daily function in a trial. Clinical trials remain an option worth asking about.

What to Expect

PKAN is progressive, but its pace varies widely. In classic PKAN, many children need a wheelchair by their mid-teens, and most lose the ability to walk independently within 10 to 15 years of the first symptoms. Some decline quickly; others plateau for long stretches. Atypical PKAN moves more slowly: many people keep walking for 15 to 40 years after onset and remain fairly independent well into adulthood. As dystonia spreads to the mouth and throat, speaking, chewing and swallowing become harder. Swallowing problems raise the risk of choking and aspiration (food or liquid entering the lungs), which is a common cause of serious illness in advanced PKAN. Many people eventually need modified foods or a feeding tube to stay nourished safely. Strong spasms combined with weak bones can cause fractures without a fall. Pain, sleep disruption and, in atypical PKAN, mood and behavior changes are part of daily life for many families. Regular follow-up lets the team adjust medicines, therapy, equipment and nutrition before problems build up. Communication aids, mobility devices and school or workplace support help people stay engaged. Palliative care specialists can help with comfort and planning alongside other treatment, and family support groups for NBIA conditions connect families facing the same rare disease.

When to Seek Help

See a doctor, ideally a neurologist, if a child or young adult develops worsening clumsiness, frequent falls, twisting postures, stiffness or new speech problems, especially if a relative has PKAN. People already diagnosed should have regular reviews of medicines, swallowing, nutrition and bone health. Contact the care team promptly if dystonia becomes clearly worse over hours to days, if coughing or choking with meals becomes frequent, or if a DBS battery may be running low or a baclofen pump alarms or seems to stop working. Do not stop baclofen or clonazepam suddenly, because abrupt withdrawal can trigger severe spasms. Status dystonicus, sometimes called a dystonic storm, is a rare but life-threatening emergency in PKAN. Seek emergency hospital care if spasms become near-continuous and keep the person from resting or sleeping, especially with severe pain, exhaustion, fever, a racing heart, or trouble breathing or swallowing.

Questions to Ask Your Doctor

  1. 1.Is this classic or atypical PKAN, and what does that suggest about how things may change over the next few years?
  2. 2.Which symptoms should we treat first, and how will we know whether a medicine is helping enough to keep it?
  3. 3.Would deep brain stimulation or a baclofen pump make sense at this stage, and what would we be trading off?
  4. 4.How should we watch for swallowing problems, and when should we talk about a feeding tube?
  5. 5.Should other family members have genetic testing, and are there clinical trials we could join?

Last reviewed • Oct 2026

Educational content, not medical advice.